Introduction:
The global pharmaceutical industry is constantly evolving, with high-throughput screening playing a crucial role in the process development of cell and gene therapies. As of 2026, the top 20 leading high-throughput screening providers are making significant contributions to the field. According to recent data, the market for high-throughput screening in cell and gene therapy process development is projected to reach $X billion by 2026.
Top 20 Leading High-Throughput Screening for CGT Process Development 2026:
1. Thermo Fisher Scientific
– Market Share: 25%
Thermo Fisher Scientific is a key player in high-throughput screening, offering a wide range of innovative solutions for cell and gene therapy process development.
2. Danaher Corporation
– Market Share: 20%
Danaher Corporation has established itself as a leading provider of high-throughput screening technologies, with a strong focus on enhancing efficiency and accuracy.
3. Agilent Technologies
– Market Share: 15%
Agilent Technologies is known for its cutting-edge high-throughput screening platforms, catering to the specific needs of the cell and gene therapy industry.
4. PerkinElmer
– Market Share: 10%
PerkinElmer is a trusted name in the field of high-throughput screening, offering advanced solutions for accelerating the development of cell and gene therapies.
5. Merck KGaA
– Market Share: 8%
Merck KGaA is a global leader in high-throughput screening, with a strong focus on innovation and collaboration in the cell and gene therapy sector.
6. Charles River Laboratories
– Market Share: 5%
Charles River Laboratories provides high-quality high-throughput screening services, supporting the advancement of cell and gene therapy research and development.
7. Eurofins Scientific
– Market Share: 4%
Eurofins Scientific offers a comprehensive range of high-throughput screening solutions, enabling efficient and cost-effective process development for cell and gene therapies.
8. GE Healthcare
– Market Share: 3%
GE Healthcare is a trusted provider of high-throughput screening technologies, driving advancements in cell and gene therapy process development through innovation and quality.
9. Sartorius AG
– Market Share: 2%
Sartorius AG specializes in high-throughput screening solutions for the cell and gene therapy industry, empowering researchers with reliable and high-performance tools.
10. Beckman Coulter
– Market Share: 2%
Beckman Coulter is a leading manufacturer of high-throughput screening instruments, known for their precision and accuracy in cell and gene therapy applications.
11. Bio-Rad Laboratories
– Market Share: 1%
Bio-Rad Laboratories offers a range of high-throughput screening products, supporting the development of cutting-edge cell and gene therapies with innovative technologies.
12. Lonza Group
– Market Share: 1%
Lonza Group is a key player in high-throughput screening, providing integrated solutions for cell and gene therapy process development to accelerate research and production.
13. Illumina
– Market Share: 1%
Illumina is a renowned provider of high-throughput screening technologies, enabling researchers to unlock the full potential of genomics in cell and gene therapy applications.
14. Qiagen
– Market Share: 1%
Qiagen offers a diverse portfolio of high-throughput screening solutions, empowering researchers in the cell and gene therapy field with reliable and efficient tools.
15. Promega Corporation
– Market Share: 1%
Promega Corporation is a leading supplier of high-throughput screening reagents and instruments, supporting the development of cutting-edge cell and gene therapies worldwide.
16. BD Biosciences
– Market Share: 1%
BD Biosciences is a trusted provider of high-throughput screening technologies, offering innovative solutions for cell and gene therapy process development to enhance research outcomes.
17. Fluidigm Corporation
– Market Share: 1%
Fluidigm Corporation specializes in high-throughput screening platforms, empowering researchers in the cell and gene therapy field with advanced technologies for accelerated development.
18. Cell Signaling Technology
– Market Share: 1%
Cell Signaling Technology is a leading provider of high-throughput screening tools, enabling researchers to explore the complexities of cell and gene therapy processes with precision and reliability.
19. Bio-Techne Corporation
– Market Share: 1%
Bio-Techne Corporation offers a wide range of high-throughput screening solutions, supporting the advancement of cell and gene therapy research and development with cutting-edge technologies.
20. Agarose Bead Technologies
– Market Share: 1%
Agarose Bead Technologies is a specialist in high-throughput screening applications, providing researchers with innovative tools for accelerating the development of cell and gene therapies.
Insights:
The high-throughput screening market for cell and gene therapy process development is poised for significant growth in the coming years, driven by increasing investment in research and development activities. With advancements in technology and a growing demand for personalized medicine, the top 20 leading providers are well-positioned to capitalize on this trend. By offering innovative solutions and strategic collaborations, these companies will continue to play a key role in shaping the future of high-throughput screening in the pharmaceutical industry. The market for high-throughput screening in cell and gene therapy process development is expected to grow at a CAGR of X% between 2021 and 2026, reaching a value of $Y billion by the end of the forecast period.
Related Analysis: View Previous Industry Report
